Clinical Trials Logo

Locally Advanced Rectal Cancer clinical trials

View clinical trials related to Locally Advanced Rectal Cancer.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04177602 Terminated - Clinical trials for Locally Advanced Rectal Cancer

Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial

Start date: November 4, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Seamless phase I/II trial with phase I part for determination of maximum tolerated dose (MTD) of Trifluridine/tipiracil, followed by a randomized phase II trial (randomization ratio 2:1) with an experimental arm with Trifluridine/tipiracil based chemoradiotherapy (CRT) and a standard - calibration arm (internal control) with capecitabine CRT flanked by translational research in patients with locally advanced rectal cancer

NCT ID: NCT03699410 Terminated - Clinical trials for Locally Advanced Rectal Cancer

Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test.

LiBReCa
Start date: August 28, 2018
Phase:
Study type: Observational

Research project for patients with locally advanced rectal cancer in which biological material and health-related personal data are collected. The aim is to investigate if an additional method (liquid biopsies) can predict the response after chemo-radiotherapy and before surgery.

NCT ID: NCT02290574 Terminated - Clinical trials for Locally Advanced Rectal Cancer

Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial

NEOTREAT
Start date: November 2014
Phase: N/A
Study type: Interventional

The investigators start this prospective study to evaluate the efficacy of laparoscopic total mesorectal excision after concurrent chemo-radiation therapy with hyperthermia in locally advanced rectal cancer.

NCT ID: NCT02151019 Terminated - Clinical trials for Locally Advanced Rectal Cancer

Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer

TRI-LARC
Start date: October 17, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The study aims to compare the incidence of acute grade 2 GI toxicity in the Control 3-D Conformal Radiotherapy compared to the Intensity Modulated Radiotherapy (IMRT) arm for locally advanced rectal cancer.